Eli Lilly
LLY
#13
Rank
HK$7.079 T
Marketcap
HK$7,898
Share price
-1.85%
Change (1 day)
22.99%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

EPS for Eli Lilly (LLY)

EPS in 2025 (TTM): HK$160.00

According to Eli Lilly's latest financial reports the company's current EPS (TTM) is HK$159.73. In 2024 the company made an earnings per share (EPS) of HK$91.69 an increase over its 2023 EPS that were of HK$43.97.

EPS history for Eli Lilly from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$160.0074.51%
2024HK$91.69108.52%
2023HK$43.97-15.84%
2022HK$52.2413.5%
2021HK$46.03-8.67%
2020HK$50.40-24.47%
2019HK$66.73176.13%
2018HK$24.17-1283.82%
2017-HK$2.04-110.57%
2016HK$19.3214.25%
2015HK$16.911.55%
2014HK$16.65-48.58%
2013HK$32.3914.25%
2012HK$28.35-6.63%
2011HK$30.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
HK$23.12-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.12-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.27-49.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.85-81.94%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$27.99-82.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
HK$10.52-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.43-36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.30-64.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
HK$23.63-85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK